All news

Merck & Co., Inc. $MRK Stake Trimmed by CX Institutional

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

CX Institutional significantly reduced its stake in Merck & Co., Inc. by 62.7% in the third quarter, selling 59,787 shares. Despite this, institutional investors still collectively own a substantial 76.07% of Merck's stock. The company reported strong quarterly revenues exceeding estimates and declared a quarterly dividend of $0.85 per share, maintaining a "Moderate Buy" consensus rating from analysts with a target price of

Read original source

MRK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.